Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Friedrich

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Cell Reports|September 19, 2019
TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector FunctionsTianqi Leng, Hossain Delowar Akther, Carl-Philipp Hackstein, et al.
Nature Immunology|September 15, 2020
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signalsPhilippos Demetriou, Enas Abu-Shah, Salvatore Valvo, et al.
Nature Immunology|October 30, 2020
Author Correction: A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signalsPhilippos Demetriou, Enas Abu-Shah, Salvatore Valvo, et al.
Nature Communications|December 3, 2022
A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and miceCarl-Philipp Hackstein, Dana Costigan, Linnea Drexhage, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2020
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung CancerMichael J Giffin, Keegan Cooke, Edward K Lobenhofer, et al.
Mucosal Immunology|October 27, 2022
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolismAthena Cavounidis, Sumeet Pandey, Melania Capitani, et al.
Gastroenterology|July 28, 2023
CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic CancerYao Xu, Juan Fu, MacKenzie Henderson, et al.
Vaccines|July 27, 2024
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
The EMBO Journal|February 16, 2023
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Cell Reports|September 19, 2019
TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector FunctionsTianqi Leng, Hossain Delowar Akther, Carl-Philipp Hackstein, et al.
Nature Immunology|September 15, 2020
A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signalsPhilippos Demetriou, Enas Abu-Shah, Salvatore Valvo, et al.
Nature Immunology|October 30, 2020
Author Correction: A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signalsPhilippos Demetriou, Enas Abu-Shah, Salvatore Valvo, et al.
Nature Communications|December 3, 2022
A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and miceCarl-Philipp Hackstein, Dana Costigan, Linnea Drexhage, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2020
AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung CancerMichael J Giffin, Keegan Cooke, Edward K Lobenhofer, et al.
Mucosal Immunology|October 27, 2022
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolismAthena Cavounidis, Sumeet Pandey, Melania Capitani, et al.
Gastroenterology|July 28, 2023
CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic CancerYao Xu, Juan Fu, MacKenzie Henderson, et al.
Vaccines|July 27, 2024
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
The EMBO Journal|February 16, 2023
Adipocyte autophagy limits gut inflammation by controlling oxylipin and IL-10Felix Clemens Richter, Matthias Friedrich, Nadja Kampschulte, et al.
Pageof 9